{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260603142757/en/Arcus-Biosciences-Announces-Clinical-Trial-Collaboration-and-Supply-Agreement-to-Evaluate-Casdatifan-in-Combination-with-PD%E2%80%91L1VEGF%E2%80%91A-Bispecific-Immunomodulator-to-Treat-Kidney-Cancer", "message": "News view counter 777189 successfully enlarged"}